Lpl Financial LLC Amarin Corp Plcuk Transaction History

Lpl Financial LLC

  • $238 Billion
  • Q4 2024

A detailed history of Lpl Financial LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Lpl Financial LLC holds 153,020 shares of AMRN stock, worth $82,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153,020
Previous 121,465 25.98%
Holding current value
$82,630
Previous $76,000 3.95%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.44 - $0.63 $13,884 - $19,879
31,555 Added 25.98%
153,020 $73,000
Q3 2024

Nov 08, 2024
SELL
$0.57 - $0.8 $7,549 - $10,596
-13,245 Reduced 9.83%
121,465 $76,000
Q2 2024

Aug 07, 2024
SELL
$0.63 - $1.07 $16,332 - $27,739
-25,925 Reduced 16.14%
134,710 $92,000
Q1 2024

May 10, 2024
BUY
$0.82 - $1.35 $15,449 - $25,435
18,841 Added 13.29%
160,635 $142,000
Q4 2023

Feb 14, 2024
BUY
$0.66 - $0.91 $6,250 - $8,617
9,470 Added 7.16%
141,794 $123,000
Q3 2023

Nov 13, 2023
BUY
$0.85 - $1.43 $1,307 - $2,199
1,538 Added 1.18%
132,324 $121,000
Q2 2023

Jul 31, 2023
SELL
$1.12 - $1.49 $26,577 - $35,357
-23,730 Reduced 15.36%
130,786 $155,000
Q1 2023

May 10, 2023
SELL
$1.19 - $2.19 $22,419 - $41,259
-18,840 Reduced 10.87%
154,516 $231,000
Q4 2022

Feb 07, 2023
SELL
$1.07 - $1.34 $35,419 - $44,356
-33,102 Reduced 16.03%
173,356 $209,000
Q3 2022

Nov 14, 2022
SELL
$1.09 - $1.67 $136,359 - $208,917
-125,100 Reduced 37.73%
206,458 $225,000
Q2 2022

Aug 12, 2022
BUY
$1.13 - $3.69 $3,084 - $10,073
2,730 Added 0.83%
331,558 $494,000
Q1 2022

May 16, 2022
BUY
$2.85 - $3.73 $132,639 - $173,594
46,540 Added 16.49%
328,828 $1.08 Million
Q4 2021

Feb 14, 2022
SELL
$3.24 - $5.18 $198,547 - $317,430
-61,280 Reduced 17.84%
282,288 $951,000
Q3 2021

Nov 15, 2021
BUY
$3.94 - $5.84 $37,288 - $55,269
9,464 Added 2.83%
343,568 $1.75 Million
Q2 2021

Aug 13, 2021
SELL
$4.26 - $6.5 $16,827 - $25,675
-3,950 Reduced 1.17%
334,104 $1.46 Million
Q1 2021

May 14, 2021
BUY
$5.03 - $8.8 $126,962 - $222,120
25,241 Added 8.07%
338,054 $2.1 Million
Q4 2020

Feb 12, 2021
BUY
$4.04 - $5.31 $337,578 - $443,698
83,559 Added 36.45%
312,813 $1.53 Million
Q3 2020

Nov 09, 2020
BUY
$3.64 - $7.76 $24,085 - $51,347
6,617 Added 2.97%
229,254 $965,000
Q2 2020

Aug 13, 2020
BUY
$4.78 - $8.26 $155,574 - $268,838
32,547 Added 17.12%
222,637 $1.54 Million
Q1 2020

May 14, 2020
BUY
$4.0 - $21.53 $128,612 - $692,254
32,153 Added 20.36%
190,090 $760,000
Q4 2019

Feb 14, 2020
SELL
$13.94 - $24.12 $629,167 - $1.09 Million
-45,134 Reduced 22.23%
157,937 $3.39 Million
Q3 2019

Nov 13, 2019
BUY
$13.89 - $23.16 $184,223 - $307,171
13,263 Added 6.99%
203,071 $3.08 Million
Q2 2019

Aug 09, 2019
BUY
$16.27 - $20.51 $754,814 - $951,520
46,393 Added 32.35%
189,808 $3.68 Million
Q1 2019

May 08, 2019
BUY
$12.61 - $22.33 $57,627 - $102,048
4,570 Added 3.29%
143,415 $2.98 Million
Q4 2018

Feb 07, 2019
BUY
$12.41 - $22.98 $17,733 - $32,838
1,429 Added 1.04%
138,845 $1.89 Million
Q3 2018

Nov 14, 2018
SELL
$2.45 - $16.27 $55,551 - $368,905
-22,674 Reduced 14.16%
137,416 $2.24 Million
Q2 2018

Aug 14, 2018
BUY
$2.68 - $3.48 $33,792 - $43,879
12,609 Added 8.55%
160,090 $495,000
Q1 2018

May 15, 2018
BUY
$2.99 - $4.44 $11,478 - $17,045
3,839 Added 2.67%
147,481 $444,000
Q4 2017

Feb 14, 2018
BUY
$3.06 - $4.09 $48,292 - $64,548
15,782 Added 12.34%
143,642 $576,000
Q3 2017

Nov 14, 2017
BUY
$3.03 - $3.72 $81,394 - $99,930
26,863 Added 26.6%
127,860 $448,000
Q2 2017

Aug 14, 2017
BUY
N/A
100,997
100,997 $407,000

Others Institutions Holding AMRN

# of Institutions
182
Shares Held
71.1M
Call Options Held
183K
Put Options Held
66.7K
View Full List

About AMARIN CORP PLCUK

AMRN Quotes by TradingView
  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $218M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email